Valuation Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:51 13/02/2026 GMT			5-day change	1st Jan Change
125.14 ^CHF	+1.08%		+4.32%	+14.18%

02-13	Sector Update: Health Care Stocks Advance Late Afternoon	MT
02-13	Sector Update: Health Care Stocks Higher Friday Afternoon	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	196,458	194,448	207,167	195,514	266,003	310,705	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	16.8%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	343,514	336,070	337,064
Change	-	-0.57%	7.71%	-2.61%	35.8%	18.51%	-2.17%	0.3%
P/E ratio	8.2x	28.3x	14.1x	16.5x	19.2x	21.5x	19.3x	16.7x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.58x	6.02x	5.45x
PEG	-	-0.4x	0x	-1x	0.9x	4.15x	1.8x	1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	5.43x	5.2x	4.93x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	6x	5.63x	5.35x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	14.7x	13.4x	12.6x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	15.7x	14.6x	13.5x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	28.2x	21.4x	18.3x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	3.55%	4.67%	5.47%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.39	4.52	4.881
Rate of return	3.83%	3.87%	3.79%	3.94%	-	2.7%	2.78%	3%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.584	8.419	9.77
Distribution rate	31.4%	110%	53.5%	65.1%	-	57.9%	53.7%	50%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	57,260	59,737	62,983
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,379	25,019	26,647
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,942	23,053	24,916
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,505	15,897	17,576
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,809	25,365	26,359
Reference price ²	87.82	90.40	100.79	97.79	138.63	162.83	162.83	162.83
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,908,152	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	31/01/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVARTIS AG	21.47x	6x	14.69x	2.7%	311B
ELI LILLY AND COMPANY	31.13x	11.79x	23.7x	0.63%	929B
JOHNSON & JOHNSON	22.11x	6.52x	18.11x	2.12%	587B
ABBVIE INC.	64.64x	7.64x	18.92x	2.82%	409B
ROCHE HOLDING AG	18.87x	4.7x	11.65x	2.79%	374B
ASTRAZENECA PLC	32.49x	5.82x	17.36x	1.58%	320B
MERCK & CO., INC.	15.68x	5.03x	10.97x	2.66%	301B
NOVO NORDISK A/S	14.81x	5.11x	10.76x	3.49%	219B
AMGEN INC.	28.69x	6.7x	11.46x	2.59%	199B
GILEAD SCIENCES, INC.	22.73x	7.03x	12.85x	2.14%	192B
Average	27.26x	6.63x	15.05x	2.35%	384.09B
Weighted average by Cap.	28.77x	7.47x	16.99x	2.05%